Today's Rundown Analysts track doubling in number of private biotech rounds Sonnet bags ex-Serono neuropathy drug via Relief Therapeutics deal Scripps bigshot who cofounded Synthorx exits amid mystery Apple healthcare researcher jumps to Gates Foundation to lead new digital health work: CNBC Stopping the spread of pancreatic cancer Featured Story | Monday, August 12, 2019 Analysts at Jefferies have tracked a doubling in the number of private life science financing rounds in two years. History suggests many of the companies backed since 2018 could IPO over the next two years, creating the next wave of biotech IPOs. |
|
| Top Stories Monday, August 12, 2019 Sonnet BioTherapeutics has struck a deal to acquire an ex-Serono drug from Relief Therapeutics. The agreement tees Sonnet up to advance the asset in chemotherapy-induced peripheral neuropathy using an equity facility worth up to $100 million. Monday, August 12, 2019 Floyd Romesberg, the renowned Scripps Research scientist and scientific founder of synthetic cytokine biotech Synthorx, has bid the institute adieu. His exit is shrouded in mystery though—and Scripps isn’t dropping any hints. Monday, August 12, 2019 The Bill & Melinda Gates Foundation has brought on one of Apple’s healthcare project leaders to serve in a new role helping lead its global digital health efforts, according to a report from CNBC. Monday, August 12, 2019 A research team discovered that some pancreatic tumors overproduce perlecan, a type of protein that helps cancer cells spread and shield themselves from chemotherapy. The finding could inspire new combination approaches to treating pancreatic cancer. Resources Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Patheon, by Thermo Fisher Scientific Patheon, part of Thermo Fisher Scientific, offers advanced API manufacturing technologies such as continuous processing and continuous analytics to deliver high-quality products with well-defined features to meet your timelines and volume requirements. Sponsored by: ICON Understanding the challenges for formulary decision makers and manufacturers. Sponsored by: Veeva This white paper details how leveraging new reporting capabilities, live UAT feedback sessions, and an agile design approach to study builds will save them time and money. Sponsored by: BBK Worldwide The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process. Sponsored by: Cambrex The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry. Sponsored by: Reprints Desk, Inc. Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Latin America Healthcare Compliance Certificate Program September 23-26, 2019 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! |